Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04290455 · ClinicalTrials.gov registry record · NA
Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04290455: Clinical Trial NA study, sponsored by University of California, Los Angeles.
NCT04290455 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04290455, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Objective: To investigate the efficacy of microblepharoexfoliation by BlephEx™ as an adjunct to eyelid cleansing in the treatment of anterior blepharitis and to validate the grading score of lid contamination to describe the severity of anterior blepharitis. Design: A prospective, randomized, paired-eye trial. Methods: One of patients' eyes will be randomized into the microblepharoexfoliation group which will use the BlephExTM device during the in-house lid cleansing procedure. The other eye will be in the control group which will receive conventional lid cleansing. The parameters indicating the efficacy of the microblepharoexfoliation procedure including the symptom scoring system; the Standard Patient Evaluation of Eye Dryness Questionnaire (SPEED), lashes contamination, lid margin redness, number of preservative free artificial tears used per day, meibomian gland quality and expressibility will be recorded at the screening visit and 3-week follow-up visit. The patient will be instructed to do warm compression and lid cleansing at home once a day with Optase eyelid scrubs for 3 weeks on both eyes before follow-up.
Interventions
- DEVICE Microblepharoexfoliative procedure with BlephEx™
- PROCEDURE Eyelid cleansing with eyelid wipes (Optase)
- PROCEDURE Daily eyelid cleansing with eyelid wipes (Optase)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-06-02 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Why NCT04290455 stopped before completion
NCT04290455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Microblepharoexfoliative procedure with BlephEx™ is the first listed.
NCT04290455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04290455 about?
NCT04290455 is a clinical study titled "Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure". Objective: To investigate the efficacy of microblepharoexfoliation by BlephEx™ as an adjunct to eyelid cleansing in the treatment of anterior blepharitis and to validate the grading score of lid contamination to describe the severity of anterior blepharitis. Design: A prospective, randomized, paired...
What is the current status of trial NCT04290455?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-06-02. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT04290455?
The interventions under investigation include: Microblepharoexfoliative procedure with BlephEx™ (DEVICE), Eyelid cleansing with eyelid wipes (Optase) (PROCEDURE), Daily eyelid cleansing with eyelid wipes (Optase) (PROCEDURE).
Who is sponsoring clinical trial NCT04290455?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04290455's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI